400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2021-05-23
临床阶段免疫肿瘤学研究商
医药研发/制造
化学&生物药
Point 72;
Point 72;
3×5 Partners;
3×5 Partners;
Eventide Asset Management;
Roche Venture Fund;
Avego Healthcare Capital;
Adage Capital Management;
Cowen Healthcare Investments;
Lightchain;
RiverVest;
Broadfin Capital;
2021-04-27
临床阶段免疫肿瘤学研究商
医药研发/制造
化学&生物药
Point 72;
Point 72;
3×5 Partners;
3×5 Partners;
Eventide Asset Management;
Avego Healthcare Capital;
Adage Capital Management;
Cowen Healthcare Investments
动脉网-最新2026-06-10
求实药社2026-06-10
中国经营报2026-06-10
功能与专用化学品2026-06-10
中国医药报2026-06-10
动脉网-最新2026-06-10
中国农业科学院2026-06-10
药融圈info2026-06-10
精准药物2026-06-10
医药观澜2026-06-10